Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GBR 13069 is a dopamine uptake inhibitor.1 It selectively inhibits dopamine uptake over norepinephrine uptake in rat occipital cortex slices (IC50s = 40 and 800 nM, respectively). GBR 13069 (2.5, 5, and 10 mg/kg) induces ipsilateral rotation and increases locomotion in rats. It also prevents 2’-CH3-MPTP-induced decreases in neostriatal levels of the endogenous catecholamine dopamine (Item No. 36532) and its metabolites DOPAC (3,4-dihydroxyphenylacetic acid; Item No. 24912) and homovanillic acid (HVA; Item No. 27307) in mice when administered at a dose of 5 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103(3-4), 241-248 (1984).
2. Characteristics of 1-